A 6-month open-label extension study of the safety and...

  • Main
  • 2018 / 05
  • A 6-month open-label extension study of the safety and...

A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus

Doria, A, Bass, D, Schwarting, A, Hammer, A, Gordon, D, Scheinberg, M, Fox, N L, Groark, J, Stohl, W, Kleoudis, C, Roth, D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Lupus
DOI:
10.1177/0961203318777634
Date:
May, 2018
File:
PDF, 274 KB
english, 2018
Conversion to is in progress
Conversion to is failed